A safety study of oral valganciclovir maintenance treatment of cytomegalovirus retinitis

Journal of Acquired Immune Deficiency Syndromes

Volumn 30, Issue 4, 2002, Pages 392-400

  Lalezari, Jacob ^a   Lindley, Janette ^a   Walmsley, Sharon ^a   Kuppermann, Baruch ^a   Fisher, Martin ^a   Friedberg, Dorothy ^a   Lalonde, Richard ^a   Matheron, Sophie ^a   Nieto, Leopoldo ^a   Torriani, Francesca J ^a   Van Syoc, Rod ^a   Sutton, Mary Ann ^a   Buhles, William ^a   Stempien, Mary Jean ^a  

^a Quest Clinical Research   (United States)

Author keywords

AIDS; Cytomegalovirus; Ganciclovir; Opportunistic infection; Retinitis; Valganciclovir

Indexed keywords

AMPHOTERICIN; DIDANOSINE; HYDROXYUREA; VALGANCICLOVIR; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANEMIA; AREA UNDER THE CURVE; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; CYTOMEGALOVIRUS; DERMATITIS; DIARRHEA; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FATIGUE; FEMALE; FEVER; HEADACHE; HUMAN; INSOMNIA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; NEUTROPENIA; NEUTROPHIL; PRIORITY JOURNAL; RADICULOPATHY; RETINA DETACHMENT; RETINITIS; RHINOPHARYNGITIS; SINGLE BLIND PROCEDURE; SURVIVAL RATE; THRUSH; TREATMENT OUTCOME; VOMITING;

EID: 0036683067     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-200208010-00004     Document Type: Article

References (27)

1. Drug therapy, ganciclovir
2. Drug therapy, treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome
3. Treatment of serious cytomegalovirus infections with 9-(1,3-dihydroxy-2-propoxymethyl) guanine in patients with AIDS and other immunodeficiencies
4. A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS
5. Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial
6. Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: The HPMPC peripheral cytomegalovirus retinitis trial. A randomized controlled trial
7. Ganciclovir: A pharmacoeconomic review of its use as intravenous or oral maintenance therapy in the management of cytomegalovirus retinitis in patients with AIDS
8. German health economic cost evaluation on oral ganciclovir in treating cytomegalovirus retinitis
9. Ganciclovir evaluation in AIDS patients with cytomegalovirus retinitis: A European study of treatment patterns and resource utilization
10. Pharmacokinetic, safety, and antiviral profiles of oral ganciclovir in persons infected with human immunodeficiency virus: A phase I/II study
11. Intravenous versus oral ganciclovir: European/Australian comparative study of efficacy and safety in the prevention of cytomegalovirus retinitis recurrence in patients with AIDS
12. Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS
13. Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS
14. Randomized trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients
15. CMV retinitis recurs after stopping treatment in virological and immunological failures of potent antiretroviral therapy
16. Pharmacokinetics of valganciclovir and ganciclovir following multiple oral dosages of valganciclovir in HIV- and CMV-seropositive volunteers
17. Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients
18. High dose oral ganciclovir treatment for cytomegalovirus retinitis
19. Valganciclovir vs IV ganciclovir as induction therapy for newly diagnosed cytomegalovirus retinitis: A randomized, controlled study
20. Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS
21. Measuring visual function and quality of life in patients with cytomegalovirus retinitis. Development of a questionnaire
22. Pharmacokinetics of oral ganciclovir alone and in combination with zidovudine, didanosine, and probenecid in HIV-infected subjects
23. Manifestations resembling thrombotic microangiopathy in patients with advanced human immunodeficiency virus (HIV) disease in a cytomegalovirus prophylaxis trial (ACTG 204)
24. Cytovene Product Information
25. Discontinuing anticytomegalovirus therapy in patients with immune reconstitution after combination antiretroviral therapy
26. Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy
27. Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis